{"metadata":{"topics":["Accountability","Accounting","Administrative law","Agencies of the United States government","Analysis","Applied ethics","Appraised value","Appraiser","Artificial objects","Asset","Assignment (law)","Audit","Average","Balance sheet","Bank","Banking","Bid–ask spread","Blue sky law","Bond (finance)","British Virgin Islands","Business","Business economics","Business law","Business organizations","Capital (economics)","Capital market","Cash","Chief executive officer","China","Choice of law","Civil law (common law)","Civil law (legal system)","Common law","Common stock","Communication","Companies","Company","Comparative law","Concealed carry in the United States","Conflict (process)","Consent","Consolidation (business)","Contract","Contract law","Control premium","Conveyancing","Corporate finance","Corporate governance","Corporate jargon","Corporate law","Corporate personhood","Corporate title","Corporation","Corporations","Covenant (law)","Credit","Credit union","Culture","Damages","Debt","Derivatives (finance)","Diqing Tibetan Autonomous Prefecture","Dividend","Doctrines","Documents","Economic law","Economic sectors","Economics","Economies","Economies of Europe","Economy","Economy of Europe","Economy of the United States","Environmental law","Equity securities","Ethical principles","European Union member economies","Exercise","Expense","Fair market value","Fee","Finance","Financial Industry Regulatory Authority","Financial accounting","Financial economics","Financial law","Financial markets","Financial regulation","Financial risk","Financial services","Financial statement","Financial statements","Financial transaction","Floor","Foreign corporation","Fraction (mathematics)","Good faith","Governance","Government","Government agencies","Government information","Government of the United States","Guarantee","Hubei","Human activities","Income","Indemnity","Industries","Information","Initial public offering","Insurance","Intellectual works","Interest","Investment","Investment banking","Issuer","Jargon","Jiang'an District","Jurisdiction","Jurisprudence","Justice","Land law","Law","Law and economics","Law of obligations","Lawyer","Legal concepts","Legal doctrines and principles","Legal documents","Legal ethics","Legal fictions","Legal liability","Legal writing","Liability (financial accounting)","Liquidation","Loan","Mail","Management","Market (economics)","Market liquidity","Market value","Marketing","Marketplace","Medication","Memorandum","Mergers and acquisitions","Microeconomics","Money","Morality","NASDAQ","National security","Natural number","Natural resources law","Negotiation","Nothing","Number","Official documents","Opinion","Option (finance)","Over-the-counter (finance)","Par value","Payment","Payments","Percentage","Personal finance","Personality traits","Political economy","Politics","Power of attorney","Price","Principles","Private law","Property","Property law","Prospectus (finance)","Public administration","Public law","Public policy","Public sphere","Ratio","Real estate","Real estate appraisal","Real property law","Recapitalization","Receipt","Registered mail","Registration statement","Regulation","Regulatory compliance","Revenue","Richmond, Virginia","Rights","Risk","Rules","Savings and loan association","Securities (finance)","Securities Act of 1933","Securities Exchange Act of 1934","Securities regulation in the United States","Security (finance)","Service industries","Service of process","Services (economics)","Severability","Shangri-La","Shangri-La City","Share (finance)","Shareholder","Shares outstanding","Signature","Social institutions","Sociological theories","Sources","Stock","Stock certificate","Stock exchange","Stock market","Stockbroker","Subscription business model","Tax","Technology","Tenor","Theories of law","U.S. Securities and Exchange Commission","Underwriting","United Kingdom","United States","United States Postal Service","United States business law","United States dollar","United States federal policy","United States law","United States regulations","United States securities law","Urban, rural, and regional economics","Valuation (finance)","Value (ethics)","Virginia","Virtue","Warrant (finance)","Warranty","Witness","Word","Written communication","Wuhan","Yunnan"],"person_names":["anderson","hanying li","jiangjing mansion","pledge or hypothecate any of its rights pursuant to this warrant other than to bona fide officers of anderson","strudwick","taylor z. gao","yanjiang ave"],"vars":{},"organization_names":["anderson & strudwick","commission","hypothecate","inc.","nasdaq capital market","nasdaq national market","registrable securities","shangri-la tibetan  pharmaceuticals inc.","shangri-la tibetan pharmaceuticals","shangri-la tibetan pharmaceuticals, inc.","shangri-la tibetan pharmacueticals","suite f","tibetan pharmaceuticals","u.s. mail","united states mail"],"agreement_id":"47afd8443397a63976ddaba5f7be458fd268acee887431c750ca6b8556e8d716","terms":["***[Execution Page Follows  Shangri-La Tibetan Pharmaceuticals, Inc.  Warrant Agreement]***","***[Execution Page  Shangri-La Tibetan Pharmaceuticals, Inc.  Warrant Agreement]***","**ANDERSON & STRUDWICK, INCORPORATED**","**Adjustment for Reorganization, Consolidation, Merger, Etc**","**Adjustment of Number of Shares Purchasable**","**Assignment; Replacement of Warrant**","**COMMON SHARES PURCHASE WARRANT**","**Cashless Exercise**","**Certificate as to Adjustments**","**Covenants of the Company With Respect to Registration**","**Current Value**","**Definition**","**Demand Registration Under the Securities Act of 1933**","**Dividends, Subdivisions, Reclassifications, Etc**","**EXHIBIT A**","**EXHIBIT B**","**EXHIBIT C**","**Exercise for Cash**","**Exercise of Warrant**","**FORM OF ASSIGNMENT**","**FORM OF SUBSCRIPTION**","**Governing Law**","**Headings**","**Issuance of Certificates**","**Issuance of Warrant; Exercise Price**","**Minimum Adjustment**","**No Impairment**","**Notice to Be Delivered**","**Notices of Record Date**","**Notices**","**PHARMACEUTICALS, INC.**","**Protection Against Dilution**","**Registration Rights**","**Restrictive Legend**","**Rights of Shareholders**","**SHANGRI-LA TIBETAN PHARMACEUTICALS, INC.**","**SHANGRI-LA TIBETAN**","**Severability**","**Stock Exchange Listing**","**Successors and Assigns; Binding Effect**","**WARRANT AGREEMENT**","*bona fide*","“1934 Act”","“Appraiser”","“Commission”","“Company”","“Exercise Period”","“Exercise Price”","“FINRA”","“IPO”","“Negotiation Period”","“Placement Agreement”","“Valuation Event”","“Warrant Agreement”","“Warrant”"]}}